Abstract CT129: A Multicohort, Open-Label, Phase 2 Basket Study of the Coformulation of Vibostolimab with Pembrolizumab, with or Without Other Anticancer Therapies, in Select Solid Tumors
Cancer Research（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined